This cluster is a vesting-driven sell pattern, not a material bearish signal. Monitor for any follow-on open-market sales by these insiders over the next 30 days; if additional sales occur without prior derivative exercises, the signal would strengthen. The company has no cross-filing context suggesting distress (no NT, no offering, no restatement), so this cluster alone does not warrant a bearish read.
CTNM drugs
CTNM drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Jul 6 $15.53entry
- T+1 · 4mo ago −6.25%α −5.77% · $14.56
- T+5 · 4mo ago −5.86%α −5.58% · $14.62
- T+20 · 4mo ago +2.58%α +1.73% · $15.93
- T+60 · 7w ago −25.95%α −27.67% · $11.50
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Three top insiders (CEO, CSO, and CMO) at Contineum Therapeutics exercised and sold shares in a coordinated cluster totaling ~$796K in open-market sales on June 30, 2026. The cluster is entirely sell-side with a clear pattern of derivative exercises paired with immediate share sales, indicating a liquidity/vesting-driven event rather than a uniform bearish conviction call. At ~0.14% of the $570M market cap, the total is modest and within routine proportionality, despite the C-suite breadth.
Key Financial Metrics
Key Facts
- Three insiders sold 37,186 shares in open-market sales on June 30- July 1, 2026, totaling ~$796K.
- CEO Carmine Stengone sold 10,000 shares ($160K); CSO Daniel Lorrain sold 28,826 shares ($462K); CMO Tim Watkins sold 10,833 shares ($174K).
- Each insider exercised stock options (prices $0-$4.50) immediately prior to or concurrent with the sales, a typical vesting-and-sell pattern.
- Total open-market sales represent ~0.14% of the company's $570M market cap, below the 0.5% threshold for a notable cluster.
Financial Impact
Total insider sales of $796K, representing 0.14% of market cap; non-cash derivative exercises had no market impact.
Risk Factors
- Insider selling tends to be a weak forward indicator for a single cluster; cluster sells are less informative than cluster buys per the literature.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-CTNM-1783063046737 |
Track record
14 reports on CTNM
Filters
- Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $9.72 Now $9.67 −0.46% settles Dec 15
- Nov 10, 20266d ago Institutional Cluster Neutral 2/10 Entry $10.56 Now $9.67 −8.43% settles Dec 9
- Nov 6, 202610d ago SC 13G/A Neutral 3/10 Entry $9.52 Now $9.67 +1.58% settles Dec 7
- Nov 5, 202611d ago SC 13G Neutral 4/10 Entry $8.81 Now $9.67 +9.76% settles Dec 4
- Nov 4, 202612d ago 144 Neutral 2/10 Entry $8.81 Now $9.67 +9.76% settles Dec 4
- Nov 3, 202613d ago 8-K Neutral 3/10 Entry $9.79 Now $9.67 −1.23% settles Dec 3
- Oct 28, 202619d ago SC 13G Neutral 3/10 Entry $9.33 Now $9.67 +3.64% settles Nov 27
- Oct 28, 202619d ago SC 13G/A Neutral 2/10 Entry $9.15 Now $9.67 +5.68% settles Nov 25
- Oct 22, 202625d ago SC 13G Neutral 3/10 Entry $8.31 Now $9.67 +16.37% settles Nov 20
- Sep 22, 20267w ago Institutional Cluster Mixed 3/10 Entry $13.40 to $8.46 Now $9.67 −27.84% ▼ −36.87% −36.31% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers